WPC
JAZZ icon

Wedmont Private Capital’s Jazz Pharmaceuticals JAZZ Stock Holding History

Wedmont Private Capital’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$681K Buy
3,062
+588
+24% +$145K 0.02% 498
2026
Q2 		$603K Buy
2,474
+171
+7% +$37.5K 0.02% 488
2026
Q1 		$451K Buy
2,303
+18
+0.8% +$3.15K 0.01% 531
2025
Q4 		$387K Buy
2,285
+22
+1% +$3.37K 0.01% 562
2025
Q3 		$311K Buy
2,263
+262
+13% +$31.4K 0.01% 611
2025
Q2 		$223K Sell
2,001
-3,911
-66% -$425K 0.01% 691
2025
Q1 		$594K Sell
5,912
-903
-13% -$118K 0.03% 334
2024
Q4 		$827K Buy
6,815
+1,843
+37% +$217K 0.04% 265
2024
Q3 		$540K Buy
4,972
+507
+11% +$55.6K 0.03% 332
2024
Q2 		$471K Buy
4,465
+2,584
+137% +$284K 0.03% 360
2024
Q1 		$214K Buy
+1,881
New +$230K 0.02% 551

Other funds holding JAZZ

ACM
Argent Capital Management St Louis, Missouri $3.14B AUM 31.36% 1-Year Est. Return
CI
CX Institutional Auburn, Indiana $3.69B AUM 15.82% 1-Year Est. Return
TFA
Toth Financial Advisory Leesburg, Virginia $1B AUM 19.18% 1-Year Est. Return
PC
Parrish Capital Kennesaw, Georgia $103M AUM 35.11% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
BONH
Bank of New Hampshire Laconia, New Hampshire $463M AUM 23.57% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
VAG
VisionPoint Advisory Group Dallas, Texas $636M AUM 21.4% 1-Year Est. Return
YIA
YHB Investment Advisors West Hartford, Connecticut $1.59B AUM 21.04% 1-Year Est. Return

Wedmont Private Capital's JAZZ Position: Q3 2026 in Review

Wedmont Private Capital increased its Jazz Pharmaceuticals (JAZZ) stake by 24% in Q3 2026, buying an estimated $145K and bringing the position to 3,062 shares worth $681K. The position accounts for 0.02% of the portfolio, ranked #498.

Wedmont Private Capital first reported a position in JAZZ in Q1 2024 and has held it in 11 quarters since. The position peaked at $827K in Q4 2024. 21 funds tracked by Wall St. Rank hold JAZZ as of Q3 2026.

  • Wedmont Private Capital held 3,062 shares of Jazz Pharmaceuticals worth $681K as of Q3 2026.
  • Wedmont Private Capital bought 588 Jazz Pharmaceuticals shares in Q3 2026, an estimated $145K.
  • Jazz Pharmaceuticals made up 0.02% of Wedmont Private Capital's portfolio in Q3 2026, its #498 holding.
  • Wedmont Private Capital first reported a position in Jazz Pharmaceuticals in Q1 2024 and has held it in 11 quarters since.
  • Wedmont Private Capital's Jazz Pharmaceuticals position peaked at $827K in Q4 2024.
  • 21 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2026.

Based on Wedmont Private Capital's 13F filing for Q3 2026, filed 9 Oct 2026.